Home/Filings/4/0001209191-23-058881
4//SEC Filing

Keyt Bruce 4

Accession 0001209191-23-058881

CIK 0001496323other

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 7:19 PM ET

Size

6.1 KB

Accession

0001209191-23-058881

Insider Transaction Report

Form 4
Period: 2023-12-13
Keyt Bruce
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2023-12-13$5.78/sh7,574$43,764129,551 total
Holdings
  • Common Stock

    (indirect: See footnote)
    1,013
Footnotes (3)
  • [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
  • [F2]This transaction was executed in multiple trades at prices ranging from $5.58 to $6.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  • [F3]The shares are held directly by the Reporting Person's spouse.

Issuer

IGM Biosciences, Inc.

CIK 0001496323

Entity typeother

Related Parties

1
  • filerCIK 0001787362

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 7:19 PM ET
Size
6.1 KB